Auglýst eftir umsóknum í norræna verkefnið Personalised Medicine


Umsóknarfrestur er til 4. september 2018 kl. 11:00 (13:00 CET).

Tækniþróunarsjóður hefur ákveðið að taka þátt í samnorræna verkefninu Personalised Medicine, sem snýr að þverfaglegu samstarfi á heilbrigðissviði.

Gera má ráð fyrir að á þessu sviði verði mikil nýsköpun á á komandi árum. Norrænir sjóðir ásamt Nordforsk hafa skuldbundið fjármagn að upphæð um 15 millj. evra í verkefnið.

Birt hefur verið auglýsing þar sem kallað er eftir umsóknum en umsóknarfrestur er 4. september 2018 kl. 11:00 (13:00 CET). 

Reglur Tækniþróunarsjóðs verða lagðar til grundvallar fyrir íslenska umsækjendur.

 Lesa auglýsingu og sækja um

Upplýsingar um verkefnið veita:
Hallgrímur Jónasson 
Ægir Þór Þórsson

Nánari upplýsingar um verkefnið (á ensku)

The Icelandic Centre for Research (RANNÍS), Innovaatiorahoituskeskus Business Finland, Innovation Fund Denmark , the Research Council of Norway and the Swedish Governmental Agency for Innovation Systems ( VINNOVA ), in collaboration with NordForsk , are launching a call for proposals with the aim of funding Nordic projects that contribute to implementation of PM in health care. The call builds on strengths and synergies in the Nordic countries. The total funding budget is EUR15 million. Personalised medicine (PM) is an interdisciplinary field that will be high on the health research and innovation agenda for years to come.

Personalised medicine is an interdisciplinary field that will drive the health research and innovation agenda for years to come. Research and innovation in this area is moving rapidly, but in a rather fragmented fashion. The implementation of personalised medicine in health care is moving forward in areas such as cancer, where most successful opportunities have been identified, but progress is slow within most other indication areas.

Partnerships and innovation networks are needed to encourage cross-disciplinary and cross-border collaboration in order to advance the field. It is of the utmost importance that research, industry, health care sectors and society jointly address challenges related to regulatory and legal frameworks, policy, payment mechanisms and health economics, etc., to overcome barriers to the implementation of PM.

This call is specifically aimed at developing innovations related to the implementation of personalised medicine for citizens and health care systems. It is intended to build on strengths and synergies between the Nordic countries.

The overall goals of NordicPermed are:

  • To promote implementation of new personalised medicine approaches for more effective and sustainable health care for the benefit of patients, citizens and society;
  • To improve the Nordic position in personalised medicine by creating a platform for research, innovation and business that will build on Nordic strengths;
  • To increase collaboration between companies, research-performing organisations and public organisations (hospitals and relevant agencies) and civil society;
  • To promote Responsible Research and Innovation perspectives in personalised medicine within a Nordic context including diversity, inclusion, openness and transparency;
  • To contribute to the action plan of the EU initiative International Consortium for Personalised Medicine.

The scope of the call focuses on three challenges related to implementation of PM

  • Data: Knowledge and value generation, based on use of cross-Nordic omics and health care data, for PM purposes, leading to new PM hypotheses to e.g. be tested in the clinic, and for supporting development of best data practices (access, quality and harmonisation) across the Nordic countries.
  • Clinical/regulatory: Development and implementation of solutions to overcome clinical and regulatory challenges related to PM.
  • Health economics: Research and development of health economics models that are useful in a PM setting.

Þetta vefsvæði byggir á Eplica